Cohen, 29, ran the New York City Marathon on Nov. 2 with NYRR's Team Inspire and now feels “at peace” Her accomplishment will “help our sickle cell warriors achieve whatever they want,” Dr. Sharl Azar ...
Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s Non-Hodgkins lymphoma (NHL). Long-term evaluable patients demonstrate ongoing ...
VANCOUVER, British Columbia – Ballard Power Systems (NASDAQ:BLDP)(TSX:BLD) and Millennium Cell, a technology solutions company that has created an energy dense proprietary technology to safely store, ...
NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (INKT) cell therapies, today announced the publication of another landmark case in Nature’s Oncogene describing a complete and ...
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial ...
Technology Adoption Program (TAP) program success demonstrates the ability of Cellares’ IDMO Smart Factory to automate, lower costs and scale out manufacturing for Cabaletta Bio’s clinical-stage CAR T ...
The researchers, led by chemistry professor Zan Luthey-Schulten at the University of Illinois Urbana-Champaign, present their findings in the journal Cell. In two videos, researchers describe the work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results